news Report calls for action to prevent confusion over medicinesBy Niamh Marriott (Junior Editor: European Pharmaceutical Review)
news UK among top performers in access to healthcare, says new reportBy Niamh Marriott (Junior Editor: European Pharmaceutical Review)
news Kadcyla new deal means NICE positive recommendation in draft guidanceBy Niamh Marriott (Junior Editor: European Pharmaceutical Review)
news FDA accepts application for generic version of Advair DiskusBy Niamh Marriott (Junior Editor: European Pharmaceutical Review)
news AAM praises Supreme Court Ruling granting access to biosimilarsBy Niamh Marriott (Junior Editor: European Pharmaceutical Review)
news EndPoint and SmartAction partner to automate Pharma/ Biotech servicesBy Niamh Marriott (Junior Editor: European Pharmaceutical Review)
news Valeant announces sale of iNova Pharmaceuticals for $930 millionBy Niamh Marriott (European Pharmaceutical Review)
news Collaboration is ‘game changer’ in delivering cell and gene therapiesBy Niamh Marriott (European Pharmaceutical Review)
news SMC rejects Perjeta (pertuzumab) for NHS use for breast cancerBy Niamh Marriott (Junior Editor: European Pharmaceutical Review)
news Health leaders launch Alliance for Transparent & Affordable PrescriptionsBy Niamh Marriott (European Pharmaceutical Review)
news Pfizer and Lilly receive FDA fast track designation for tanezumabBy Niamh Marriott (European Pharmaceutical Review)
news Gilead submits drug application to FDA for HIV treatmentBy Niamh Marriott (European Pharmaceutical Review)
news NICE recommends Lilly’s Olaratumab (Lartruvo) to treat sarcomaBy Niamh Marriott (European Pharmaceutical Review)
Follow: